Abstract
Purpose: The Innovative Medicines Initiative - Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) consortium is a longitudinal cohort study to combine conventional and new disease markers and to identify different OA phenotypes. Historical data were used to train machine learning models to provide a structural and pain progression score for each individual, which was used as basis for inclusion 1. Study parameters used to assess structural progression include quantitative MRI of cartilage including thickness and semi-quantitative MRI scoring of cartilaginous and non-cartilaginous features of OA.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
